Vanguard Capital Management’s ImageneBio IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.47M Buy
321,994
+1,476
+0.5% +$8.02K ﹤0.01% 3460
2026
Q2
$1.89M Sell
320,518
-4,637
-1% -$26.2K ﹤0.01% 3443
2026
Q1
$1.63M Buy
+325,155
New +$2.11M ﹤0.01% 3431

Other funds holding IMA

Vanguard Capital Management's IMA Position: Q3 2026 in Review

Vanguard Capital Management increased its ImageneBio (IMA) stake by 0.46% in Q3 2026, buying an estimated $8.02K and bringing the position to 321,994 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

Vanguard Capital Management first reported a position in IMA in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.89M in Q2 2026. 37 funds tracked by Wall St. Rank hold IMA as of Q3 2026.

  • Vanguard Capital Management held 321,994 shares of ImageneBio worth $1.47M as of Q3 2026.
  • Vanguard Capital Management bought 1,476 ImageneBio shares in Q3 2026, an estimated $8.02K.
  • ImageneBio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3460 holding.
  • Vanguard Capital Management first reported a position in ImageneBio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's ImageneBio position peaked at $1.89M in Q2 2026.
  • 37 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.